SEARCH

SEARCH BY CITATION

References

  • 1
    Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opinion Allergy Clin Immunol 2001;1:305310.
  • 2
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998;279:12001205.
  • 3
    Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opinion Allergy Clin Immunol 2005;5:309316.
  • 4
    Johansson SGO, Hourihane JO’B, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T et al. Position paper. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813824.
  • 5
    Executive summary of disease management of drug hypersensitivity: a practice parameter. Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma, and Immunology and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1999;83 (6 pt 3):665700.
  • 6
    Drain KL, Volcheck GW. Preventing and managing drug-induced anaphylaxis. Drug Saf 2001;24:843853.
  • 7
    Van Der Klauw M, Wilson J, Stricker B. Drug-associated anaphylaxis: 20 years of reporting in the Netherlands 1974–1994 and review of the literature. Clin Exp Allergy 1996;26:13551363.
  • 8
    Torres MJ, Mayorca C, Blanca M. Drug Hypersensitivity. In: PichlerW, editor. Urticaria and anaphylaxis due to Betalactams (Penicillins and Cephalosporins). Bern: Karger Verlag, 2007: 190203.
  • 9
    Neukomm C, Yawalkar N, Helbling A, Pichler WJ. T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J Invest Allergy Clin Immunol 2001;11:275284.
  • 10
    Mockenhaupt M. Dermatology and Venerology. In: BurgdorfWHC, PlewigG, WolffHH, LandthalerM, Braun-Falco’s , editors. Severe cutaneous adverse reactions. Heidelberg: Springer Medizin Verlag, 2008:473484.
  • 11
    Allanore L, Roujeau J-C. Drug Hypersensitivity. In: PichlerW, editor. Clinic and pathogenesis of Severe Bullous Skin Reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis. Bern: Karger Verlag, 2007:267277.
  • 12
    Straumann A, Bauer M, Pichler WJ, Pirovino M. Acute pancreatitis due to pyritynol. Gastroenterology 1998;115:452454.
  • 13
    Maria VA, Victorino RM. Diagnostic value of specific T-cell reactivity to drugs in 95 cases of drug induced liver injury. Gut 1997;41:534540.
  • 14
    Naisbitt DJ, Gordon SF, Pirmohamed M, Park BK. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf 2000;23:483507.
  • 15
    Pichler WJ, Yawalkar N, Britschgi M, Depta J, Strasser I, Schmid S et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 2002;3:229238.
  • 16
    Pichler WJ, Yawalkar N, Schmid S, Helbling A. Pathogenesis of drug induced exanthems. Allergy 2002;57:884893.
  • 17
    Britschgi M, Steiner U, Schmid S, Depta JP, Senti G, Bircher A et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001;11:14331441.
  • 18
    Adkinson NF Jr. Allergy, Principles and Practice. In: MiddletonEJr, AdkinsonNFJr, YungingerJW, BusseWW, BochnerBS, HolgateST, SimonsER, editors. Drug allergy. New York: Mosby Co, 2003:16791694
  • 19
    Bousquet J, Bieber T, Fokkens W, Humbert M, Kowalski ML, Niggemann B et al. Consensus statements, evidence-based medicine and guidelines in allergic diseases. Allergy 2008;63:14.
  • 20
    Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 2006;6:476481.
  • 21
    Solensky R. Drug hypersensitivity. Med Clin North Am 2006;90:233260.
  • 22
    Solensky R. Drug desensitization. Immunol Allergy Clin North Am 2004;24:425443.
  • 23
    Turvey SE, Cronin B, Arnold AD, Dioun AF. Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Ann Allergy Asthma Immunol 2004;92:426432.
  • 24
    Markman M, Kennedy A, Webster K, Elson P, Peterson G, Kulp B et al. Clinical features of hypersensitivity reactions to carboplatin. J Clin Oncol 1999;17:11411145.
  • 25
    Zanotti KM, Rybicki LA, Kennedy AW, Belinson JL, Webster KD, Kulp B et al. Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 2001;19:31263129.
  • 26
    Berges-Gimeno MP, Stevenson DD. Nonsteroidal anti-inflammatory drug induced reactions and desensitization. J Asthma 2004;41:375384.
  • 27
    Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2003;111:180186.
  • 28
    Berges-Gimeno MP, Simon RA, Stevenson DD. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2003;90:338341.
  • 29
    Feldweg AM, Lee CW, Matulonis UA, Castells M. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments. Gynecol Oncol 2005;96:824829.
  • 30
    Sobotka A, Dembo M, Goldstein B, Lichtenstein L. Antigen specific desensitization of human basophils. J Immunol 1979;122:511517.
  • 31
    Shalit M, Levi-Schaffer F. Challenge of mast cells with increasing amounts of antigen induces desensitization. Clin Exp Allergy 1995;25:896902.
  • 32
    Steinman RM, Mellman IS, Muller MA, Cohen ZA. Endocytosis and recycling of plasma membrane. J Cell Biol 1983;96:127.
  • 33
    Kepley CL. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels. Int Arch Allergy Immunol 2005;138:2939.
  • 34
    Odom S, Gomez G, Kovarova M, Furumoto Y, Ryan JJ, Wright HV et al. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med 2004;199:14911502.
  • 35
    Malaviya R, Uckum FM. Role of STAT6 in IgE receptor/FcepsilonRI-mediated late phase allergic responses of mast cell. J Immunol 2002;168:421426.
  • 36
    Shimoda K, Van DeursenJ, Sangster MY, Sarawar SR, Carson RT, Tripp RA et al. Lack of IL-4 induced Th2 response and IgE class switching in mice with disrupted STAT6 gene. Nature 1996;380:630633.
  • 37
    Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S et al. Essential role of STAT6 in IL-4 signaling. Nature 1996;380:627630.
  • 38
    Morales AR, Shah N, Castells M. Antigen-IgE desensitization in signal transducer and activator of transcription 6–deficient mast cells by suboptimal doses of antigen. Ann Allergy Asthma Immunol 2005;94:575580.
  • 39
    Woo HY, Kim YS, Kang NI, Chung WC, Song CH, Choi IW et al. Mechanism for acute oral desensitization to antibiotics. Allergy 2006;61:954958.
  • 40
    Farooque S, Lee T. Mechanisms of aspirin-sensitive respiratory disease-a two-compartment model. Int Arch Allergy Immunol 2007;142:5963.
  • 41
    Castells M. Drug Hypersensitivity. In: PichlerW, editor. Drug desensitization in oncology: chemotherapy agents and monoclonal antibodies. Bern: Karger Verlag, 2007:413425.
  • 42
    Bonfanti P, Pusterla L, Parazzini F, Libanore M, Cgni AE, Franzetti M et al. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. Biomed Pharmacother 2000;54:5659.
  • 43
    Gorman SK, Zed PJ, Dhingra VK, Ronco JJ. Rapid imipenem/cilastatin desensitization for multidrug-resistant Acinetobacter pneumonia. Ann Pharmacother 2003;37:513516.
  • 44
    Shiohara T, Takahashi R, Kano Y. Drug Hypersensitivity. In: PichlerW, editor. Drug-induced hypersensitivity syndromes and viral reactivation. Bern: Karger Verlag, 2007:251266.
  • 45
    Gruchalla R. Acute drug desensitization. Clin Exp Allergy 1998;28:6364.
  • 46
    Lee CW, Matulonis UA, Castells MC. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol 2004;95:370376.
  • 47
    Boguniewicz M, Leung DY. Management of patients with allergic reactions to antibiotics. Pediatr Pulmunol 1987;80:314319.
  • 48
    Lee CW, Matulonis UA, Castells MC. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses. Gynecol Oncol 2005;99:393399.
  • 49
    Borish L, Tamir R, Rosenwasser LJ. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987;80:314319.
  • 50
    Sullivan TJ, Yecies LD, Shatz GS, Parker CW, Wedner HJ. Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. J Allergy Clin Immunol 1982;69:275282.
  • 51
    Demoly P, Messaad D, Sahla H, Fabre J, Faucherre V, Andre P et al. Six-hour trimethoprim-sulfamethoxazole graded challenge in HIV-infected patients. J Allergy Clin Immunol 1998;102:10331036.
  • 52
    Ghosal S, Taylor CJ. Intravenous desensitization to ceftazidime in cystic fibrosis patients. J Antimicrob Chemother 1997;39:556557.
  • 53
    Earl HS, Sullivan TJ. Acute desensitization of a patient with cystic fibrosis allergic to both betalactam and aminoglycoside antibiotics. J Allergy Clin Immunol 1987;79:477483.
  • 54
    Chopra N, Oppenheimer J, Derimanov GS, Fine PL. Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels. Ann Allergy Asthma Immunol 2000;84:633635.
  • 55
    Castells M, Tennant NM, Sloane DE, Hsu FI, Barrett NA, Hong DI et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008;122:574580.
  • 56
    Solensky R. Drug Hypersensitivity. In: PichlerW, editor. Desensitization with antibiotics. Bern: Karger Verlag, 2007:404412.
  • 57
    Stark BJ, Earl HS, Gross GN, Lumry WR, Goodman EL, Sullivan TJ. Acute and chronic desensitization of penicillin allergic patients using oral penicillin. J Allergy Clin Immunol 1987;79:523532.
  • 58
    Herman R, Jick H. Cutaneous reaction rates to penicillins: oral versus parental. Cutis 1979;24:232234.
  • 59
    Sullivan TJ. Allergy, Principles and Practice. In: MiddletonEJr, ReedCE, EllisEF, AdkinsonNF, YungingerJW, editors. Drug allergy. St. Louis: Mosby Co 1993:17261746.
  • 60
    Moyes V, Driver R, Croom A, Mirakian R, Chowdhury TA. Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion. Diabet Med 2006;23:204206.
  • 61
    Radermecker RP, Scheen AJ. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Diabetes Metab Res Rev 2007;23:348355.
  • 62
    Wong JT, Ripple RE, MacLean JA, Marks DR, Bloch KJ. Vancomycin hypersensitivity: synergism with narcotics and “desensitization” by a rapid continuous intravenous protocol. J Allergy Clin Immunol 1994;94:189194.
  • 63
    Sehn LH, Donaldson J, Filewich A, Fitzgerald C, Gill KK, Runzer N et al. Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting. Blood 2007;109:41714173.
  • 64
    Wendel GD Jr, Stark BJ, Jamison RB, Molina RD, Sullivan TJ. Penicillin allergy and desensitization in serious infections during pregnancy. N Engl J Med 1985;312:12291232.
  • 65
    Madaan A, Li JT. Cephalosporin allergy. Immunol Allergy Clin North Am 2004;24:463476.
  • 66
    Empedrad R, Darter AL, Earl HS, Gruchalla RS. Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003;112:629630.
  • 67
    Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002;57:4551.
  • 68
    Torres MJ, Blanca M, Fernandez J, Romano A, De Weck A, Aberer W et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003;58:961972.
  • 69
    Burrows JA, Toon M, Bell SC. Antibiotic desensitization in adults with cystic fibrosis. Respirology 2003;8:359364.
  • 70
    Castells M. Rapid desensitization for hypersensitivity reactions to chemotherapy agents. Curr Opin Allergy Clin Immunol 2006;6:271277.
  • 71
    Morgan JS, Adams M, Mason MD. Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma. Eur J Cancer 1994;30:12051206.
  • 72
    White AA, Stevenson DD, Simon RA. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol 2005;95:330335.
  • 73
    Morgan M, Bowers DC, Gruchalla RS, Khan DA. Safety and efficacy of repeated monthly carboplatin desensitization. J Allergy Clin Immunol 2004;114:974975.
  • 74
    Brown LA, Goldberg ND, Shearer WT. Long-term ticarcillin desensitization by the continuous oral administration of penicillin. J Allergy Clin Immunol 1982;69:5154.
  • 75
    Pfaar O, Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol 2006;6:161166.
  • 76
    Graybill JR, Sande MA, Reinarz JA, Shapiro RS. Controlled penicillin anaphylaxis leading to desensitization. South Med J 1974;67:6264.
  • 77
    Markman M, Kennedy A, Webster K, Kulp P, Peterson G, Belinson J. Paclitaxel-associated hypersensitivity reactions: experience of the gynaecologic oncology program of the Cleveland Clinic Cancer Center. J Clin Oncol 2000;18:102105.
  • 78
    Ogle SK, Rose MM, Wildes CT. Development and implementation of a carboplatin desensitization protocol for children with neurofrimomatosis, type I, and hypersensitivity reactions in an outpatient oncology clinic. J Pediatr Oncol Nurs 2002;19:122126.
  • 79
    Naclerio R, Mizrahi EA, Adkinson NF Jr. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol 1983;71:294301.
  • 80
    Rodrigues J, Moreira A, Fonseca J, Vaz M. Oral desensitization to izoniazid. R Port Alergologia 2007;9:263264.
  • 81
    Buergin S, Scherer K, Hausermann P, Bircher AJ. Immediate hypersensitivity to rifampicin in 3 patients: diagnostic procedures and induction of clinical tolerance. Int Arch Allergy Immunol 2006;140:2026.
  • 82
    Straatmann A, Bahia F, Pedral-Sampaio D, Brites C. A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides. Braz J Infect Dis 2002;6:276280.
  • 83
    Yoshizawa S, Yasuoka A, Kikuchi Y, Honda M, Gatanaga H, Tachikawa N et al. A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S. Ann Allergy Asthma Immunol 2000;85:241244.
  • 84
    Theodore CM, Holmes D, Rodgers M, McLean KA. Co-trimoxazole desensitization in HIV-seropositive patients. Int J STD AIDS 1998;9:158161.
  • 85
    Palusci VJ, Kaul A, Lawrence RM, Haines KA, Kwittken PL. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. Pediatr Infect Dis J 1996;15:456460.
  • 86
    Amedeo J, Chichmanian RM, Reboulot B, Vinti H, Rosenthal E, Pesce A et al. Desensitization in HIV seropositive patients with cotrimoxazole hypersensitivity. A series of 18 cases. Therapie 1994;49:463465.
  • 87
    Beall G, Sanwo M, Hussain H. Drug reactions and desensitization in AIDS. Immunol Allergy Clin North Am 1997;17:319338.
  • 88
    Olson JK, Sood AK, Sorosky JI, Anderson B, Buller RE. Taxol hypersensitivity: rapid retreatment is safe and cost effective. Gynecol Oncol 1998;68:2528.
  • 89
    Rose PG, Fusco N, Smrekar M, Mossbruger K, Rodriguez M. Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity. Gynecol Oncol 2003;89:429433.
  • 90
    Somech R, Seaban-Adel K, Atkinson A, Kirby-Allen M. Evaluation and management of pediatric patients with anaphylactoid reactions to deferoxamine mesylate. Ann Allergy Asthma Immunol 2007;99:575576.
  • 91
    Atanasković-Marković M, Nestorović B. Desensitization to diphtheria, tetanus and pertussis vaccine. Srp Arh Celok Lek 2003;131:427431.
  • 92
    Williams AN, Kabuubi JB, Owen JP, Wells J. Tetanus immunisation in hypersensitive individuals. J R Army Med Corps 2002;148:148150.
  • 93
    Hsu HL, Huang FC, Ni YH, Chang MH. Steroids used to desensitize penicillamine allergy in Wilson disease. Acta Paediatr Taiwan 1999;40:448450.
  • 94
    Parekh K, Burkhart HM, Hatab A, Ross A, Muller BA. Heparin allergy: successful desensitization for cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005;130:14551456.
  • 95
    Lee JY, Simon RA, Stevenson DD. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007;119:157164.
  • 96
    Gollapudi RR, Teirstein PS, Stevenson DD, Simon RA. Aspirin sensitivity: implications for patients with coronary artery disease. JAMA 2004;292:30173023.
  • 97
    Hope AP, Woessner KA, Simon RA, Stevenson DD. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2009;123:406410.
  • 98
    Syrigou EI, Karapanagiotou EM, Alamara CV, Boura PG, Saif MW, Syrigos KN. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol. Clin Colorectal Cancer 2009;8:106109.
  • 99
    Jerath MR, Kwan M, Kannarkat M, Mirakhur B, Carey L, Valgus J et al. A desensitization protocol for the mAb cetuximab. J Allergy Clin Immunol 2009;123:260262.